Ultravate (Ranbaxy Laboratories Inc.)
Welcome to the PulseAid listing for the Ultravate drug offered from Ranbaxy Laboratories Inc.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ranbaxy Laboratories Inc. |
NON-PROPRIETARY NAME: | halobetasol propionate |
SUBSTANCE NAME: | HALOBETASOL PROPIONATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
ROUTE: | TOPICAL |
DOSAGE FORM: | OINTMENT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-02-20 |
END MARKETING DATE: | 0000-00-00 |
Ultravate HUMAN PRESCRIPTION DRUG Details:
Item Description | Ultravate from Ranbaxy Laboratories Inc. |
LABELER NAME: | Ranbaxy Laboratories Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/g) |
START MARKETING DATE: | 2009-02-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10631-102_cd9a3fc1-f9e4-4ab7-9c75-50ab9c65e270 |
PRODUCT NDC: | 10631-102 |
APPLICATION NUMBER: | NDA019968 |
Other HALOBETASOL PROPIONATE Pharmaceutical Manufacturers / Labelers: